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rods and cones (see Burns and Baylor, 2001; Arshavsky
et al., 2002, for recent reviews). In this cascade, pho-
toexcited rhodopsin activates G protein transducin
(Gt), which then stimulates the activity of the effector
enzyme, cGMP phosphodiesterase (PDE), by binding to
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Boston, Massachusetts 02114 the PDE -subunit and releasing the inhibitory constraint
that PDE imposes on the PDE catalytic subunits. The
lifetime of the activated Gt in this pathway is regulated
by the short splice isoform of RGS9, RGS9-1 (He et al.,Summary
1998; Chen et al., 2000). Critical to this regulation is the
ability of RGS9-1 to interact selectively with Gt boundRGS proteins regulate the duration of cell signaling by
modulating the lifetime of activated G proteins. The to PDE (Tsang et al., 1998), which prevents signal termi-
nation before the effector is activated by Gt . This speci-specificity of RGS-G protein mutual recognition is criti-
cal for meeting unique timing requirements of numer- ficity is achieved through the ability of PDE to increase
the affinity between RGS9-1 and Gt by over 20-foldous G protein-mediated pathways. Our study of two
splice isoforms of RGS9 expressed in different types (Skiba et al., 2000), thus targeting RGS9-1 to Gt.
Alternative splicing of RGS9 yields another isoform,of neurons revealed a novel mechanism whereby this
specificity is determined by specialized protein do- RGS9-2, where 18 C-terminal amino acid residues of
RGS9-1 are replaced by a longer sequence of 209 aminomains or subunits acting as affinity adapters. The long
RGS9 isoform contains a C-terminal domain that pro- acid residues (Granneman et al., 1998; Rahman et al.,
1999). RGS9-2 is expressed in the striatal part of thevides high-affinity interaction with its target G protein.
The lack of this domain in the short RGS9 isoform is brain (Thomas et al., 1998; Granneman et al., 1998; Rah-
man et al., 1999), where it is likely to regulate the lifetimecompensated by the action of a G protein effector
subunit that is structurally similar to this C-terminal of activated Go and/or Gi proteins, both of which belong
to the same G protein subfamily as Gt (Granneman etdomain. This allows the short isoform to specifically
target the complex between the G protein and its ef- al., 1998; Rahman et al., 1999; Kovoor et al., 2000; Hooks
et al., 2003). PDE is not expressed in the brain, whichfector. Thus, the specific timing needs of different sig-
naling pathways can be accommodated by affinity brings up the question of how RGS9-2 can specifically
recognize its target(s) in the absence of PDE.adapters positioned at various pathway components.
In this study, we demonstrate that the C-terminal do-
main of RGS9-2 plays a crucial role in setting RGS9-2Introduction
G protein recognition specificity. It targets RGS9-2 to
its specific G protein  subunit, Go, by increasing theirRGS proteins are ubiquitous negative regulators of G
protein signaling, which act by stimulating the rate of mutual binding affinity, exactly as PDE does for the
binding between RGS9-1 and transducin. Furthermore,GTP hydrolysis on G protein  subunits (Berman and
Gilman, 1998; Burchett, 2000; Ross and Wilkie, 2000; the C-terminal domain of RGS9-2 shares a significant
degree of overall structural organization and sequenceNeubig and Siderovski, 2002; Arshavsky et al., 2002).
The abundance of signaling cascades where RGS and homology with PDE. Taken together, these observa-
tions reveal a novel mechanism of setting the specificityG proteins are involved raises the issue of how specific-
ity in their mutual recognition is achieved. Most of the in RGS protein action. In this mechanism, small protein
domains or subunits, such as PDE or RGS9-2 C termi-progress in this direction has been gained by establish-
ing the patterns of preferential RGS-G protein interac- nus, act as affinity adapters between RGS proteins and
their physiological G protein targets. These adapterstions in studies that used purified proteins or proteins
expressed in cell culture (reviewed in Burchett, 2000; could be positioned at different components of the sig-
naling pathways to accommodate for their specific tim-Ross and Wilkie, 2000; Neubig and Siderovski, 2002;
Arshavsky et al., 2002). However, this information alone ing needs.
is not sufficient for understanding the specificity of RGS
protein action within a specific G protein cascade. In Results
order to ensure that the timing of the entire signaling
event provided by a given pathway is physiologically Catalytic Properties of RGS9 Splice Isoforms
appropriate, RGS proteins may also be required to dis- There is a consensus in the literature that both splice
criminate between the free activated G protein  sub- isoforms of RGS9 are suited to work with the members
units and their complexes with effectors or other regula- of Gi subfamily of G proteins. Transducin (Gt) has been
tory proteins (Arshavsky and Pugh, 1998). established as the physiological target of RGS9-1 in an
An example of a signaling pathway where an RGS array of biochemical, physiological, and genetic studies
protein interacts specifically with the G protein-effector in photoreceptors (He et al., 1998; Chen et al., 2000).
complex is the visual transduction cascade in vertebrate The attribution of Go and/or Gi as specific targets of
RGS9-2 has come mostly from studies in cell culture
(Granneman et al., 1998; Rahman et al., 1999). Until now,*Correspondence: vadim_arshavsky@meei.harvard.edu
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Figure 2. The Binding of Gt and Go to RGS9 Splice Isoforms
Attached to the Ni-NTA Agarose Beads
Both  subunits were activated by AlF4, which mimics the transition
conformation for GTP hydrolysis most favorable for binding to RGS
proteins (Tesmer et al., 1997). The amounts of Gt and Go retaining
on the beads was determined by Western blotting using antibodies
specific for each subunit.
enriched with Go (Worley et al., 1986). Interestingly,
RGS9-2 was also active with Gt, although these proteins
have not been reported to be localized in the same cells
(Rahman et al., 1999). With all three G proteins tested,
the activity of RGS9-2 was higher than the activity of
RGS9-1. PDE stimulated the activity of RGS9-1 not
only with transducin but also with Go and Gi. In all three
cases, the G protein GTPase activity level observed with
RGS9-2 alone was approximately the same as the level
observed with the combination of RGS9-1 and PDE.
Although Go and Gi are not expressed in the same cells
with PDE in vivo, this observation is consistent with
biochemical data showing that PDE can interact with
these G protein  subunits in vitro (Otto-Bruc et al.,
1994). In contrast to RGS9-1, the activity of RGS9-2 was
always inhibited by PDE, likely reflecting the competi-
tion between RGS9-2 and PDE for binding to G protein
 subunits (see below). Taken together, these data indi-
cate that RGS9-2 alone has the same catalytic proper-
Figure 1. Catalytic Properties of RGS9 Splice Isoforms Determined ties as the combination of RGS9-1 with PDE.
in the Single Turnover GTPase Assays
(A) The regulation of the GTPase activity of Gi class members in the C-Terminal Domain of RGS9-2 Is a Functional
presence or absence of PDE. Homolog of PDE
(B) The C terminus of RGS9-2 potentiates the ability of RGS9 to
Because the only difference between RGS9-1 andstimulate the GTPase activity of Go both in cis and in trans. kGAP is
RGS9-2 resides in the composition of their C termini,calculated as the difference between the rates of G protein GTPase
we conclude that the C-terminal domain of RGS9-2 playsactivity in the presence of RGS9 and the basal GTPase activity of
the same G protein (Krumins and Gilman, 2002). the same functional role in facilitating RGS9-2 interac-
tions with G protein  subunits as PDE does for
RGS9-1. This conclusion is further supported by the
observation that the C terminus of RGS9-2 expressedthe latter conclusion has not been tested in direct bio-
chemical experiments. Therefore, we conducted a ki- as an individual protein (CT) was able to enhance the
ability of RGS9-1 to stimulate the GTPase activity of Gonetic analysis of Gt, Go, and Gi GTPase regulation by
recombinant RGS9-2 and compared its catalytic proper- (Figure 1B). The effect of CT was about one half of the
effect caused by PDE when both proteins were usedties with those of RGS9-1 (Figure 1A).
In our studies, we used recombinant RGS9 isoforms at saturating concentrations.
Direct evidence that the C-terminal domain of RGS9-2complexed with their constitutive subunit, the type 5 G
protein  subunit, G5 (Snow et al., 1998; Makino et al., increases the affinity between RGS9-2 and its G protein
-subunit targets, as PDE does for RGS9-1, was ob-1999; Kovoor et al., 2000; Witherow et al., 2000). We
have found that RGS9-2 stimulates the GTPase activity tained in pull-down assays conducted with both RGS9
isoforms (Figure 2). High-affinity binding of RGS9-2 toof Go much better than that of Gi, indicating that Go is
the most likely physiological partner of RGS9-2. This Gt or Go did not require the presence of PDE,
whereas any appreciable G interaction with RGS9-1is consistent with the observation that the striatum is
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was observed only when PDE was present (cf. Skiba
et al., 1999, 2000, 2001). We also found that an excess
of PDE decreased Gt binding to RGS9-2, indicating
that PDE can compete with RGS9-2 for binding to Gt.
No reliable PDE inhibition was observed with Go. This
is different from the inhibition seen in GTPase assays
(Figure 1A) and likely reflects a higher affinity of RGS9-2
for the AlF4-activated Go used in pull-down assays
than for GTP-activated Go used in GTPase assays. This
affinity difference results in a more efficient RGS9-2
competition with PDE for binding to Go in pull-down
assays than in GTPase assays. The likely reason why
PDE still competes with RGS9-2 for Gt in pull-down
assays is that the absolute affinity of PDE for Gt is
much higher than its affinity for Go (Otto-Bruc et al.,
1994). In summary, the results obtained in pull-down
assays indicate that PDE and the C-terminal domain
of RGS9-2 act by increasing the affinity between the
RGS9 splice isoforms and their corresponding G protein
 subunit partners. For this reason, we call them “affinity
adapters.”
Additional control experiments were performed in or-
der to prove that functional properties of RGS9-1 are
different from those of RGS9-2 because RGS9-1 lacks
the PDE-like domain and not because it has its own
unique C-terminal extension. This was tested with an
RGS9 mutant completely lacking its C-terminal se-
quence beyond the RGS homology domain (DIGR mu-
tant from Skiba et al., 2001). This mutant displayed an
ability to cooperate positively with PDE and with the
C-terminal domain of RGS9-2 upon stimulating the
GTPase activity of Go (see Supplemental Figure S1 at
http://www.neuon.org/cgi/content/full/38/6/857/ Figure 3. The C-Terminal Domain of RGS9-2 Is a Structural and
Functional Analog of PDEDC1) and Gt (Skiba et al., 2001). It also cooperated with
PDE in binding both Gt and Go in pull-down assays (A) Schematic representation of domain compositions of RGS9
splice isoforms and PDE. Abbreviations: DEP, Dishevelled/EGL-10/(see Supplemental Figure S2).
Pleckstrin homology domain; GGL, G protein  subunit-like domain;
RGS, RGS homology domain. SH3 recognition motifs are marked
C-Terminal Domain of RGS9-2 Shares Common by arrowheads.
Structural Organization with PDE (B) The stimulation of Go GTPase activity by RGS9 isoforms and
Remarkably, the functional homology between PDE mutants in single turnover assays. RGS9-245 is the mutant lacking
the entire anionic region of the C terminus; RGS9-2Ala is the mutantand the C-terminal domain of RGS9-2 is paralleled by
where residues 662–667 were replaced by alanines.a significant degree of similarity in their structural organi-
(C) The binding of Go to RGS9 variants attached to the Ni-NTAzation (Figure 3A). Both of these molecules have strongly
agarose beads.
positively charged N-terminal regions with an abrupt
transition to strongly negatively charged C-terminal se-
quences. In both, the transition point is located close fore compared the catalytic activity of RGS9-2 with the
activity of the RGS9-2 mutant in which the anionic regionto the sites of exon boundaries. The cationic regions,
although different in length, are both rich in prolines was deleted (RGS9-245) and with RGS9-1, which natu-
rally lacks both regions (Figure 3B). The rate of the Goand arginines and contain conserved SH3 recognition
motifs. The anionic regions are similar in length and GTPase activity observed with the RGS9-245 mutant
was found to be intermediate between the rates ob-contain a highly homologous sequence of approxi-
mately 12 amino acids, which includes a stretch of six served with the two splice variants of RGS9. The data
from pull-down assays shown in Figure 3C indicate thatidentical amino acids.
The structural similarity between PDE and the C ter- this reduction in activity results from a reduction in the
affinity between RGS9-245 and Go. The affinity of theminus of RGS9-2 prompted us to assess the relative
contributions of cationic and anionic regions from the RGS9-245 mutant for Go in these assays was found
to be intermediate between the affinities of the RGS9C terminus of RGS9-2 in regulating the GTPase activity
of Go. It is well established that both cationic and an- splice variants (Figure 3C). Taken together, the data from
Figures 3B and 3C indicate that the cationic and anionicionic regions of PDE contribute to its high-affinity bind-
ing to Gt (reviewed in Pfister et al., 1993), with several regions of the RGS9-2 C terminus make approximately
equal contributions to its ability to serve as an affinityhydrophobic amino acids of the anionic region, including
Trp70, being crucial for the ability of PDE to facilitate adaptor between RGS9-2 and Go.
We also tested whether the six amino acid residuesRGS9-1-Gt interactions (Slepak et al., 1995). We there-
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of RGS9-2 (662–667), which are identical to the residues
66–71 of PDE, are important for activating Go GTPase
by RGS9-2. However, the activity of RGS9-2 did not
decrease when all six residues were substituted for ala-
nines (Figure 3B). These results indicate that the overall
structural organization of the affinity adaptor domains
in two different pathways is important for their function,
whereas the roles of individual amino acid residues
within these domains are not necessarily functionally
conserved.
Discussion
An unsolved puzzle in the field of signal transduction
is how the physiological timing of signaling events is
conferred through the interactions between activated G
protein  subunits and their negative regulators, RGS
proteins. To solve this problem, it is crucial to under-
stand how the specificity of G protein-RGS protein mu-
tual recognition is achieved on the molecular level. The
results obtained in this study indicate that this specificity
can be attained by the action of protein domains or
subunits serving as affinity adapters between RGS pro-
teins and their G protein  subunit partners.
Remarkably, the positioning of affinity adapters on
different molecules in various signaling pathways pro-
vides flexibility in accommodating for these pathways’
specific functional requirements. Two examples shown
in Figure 4 illustrate the consequences of placing these
adapters either on the G protein effectors or on the RGS
Figure 4. The Role of Affinity Adapters in Targeting RGS9 Spliceproteins themselves in two different neuronal pathways.
Isoforms to G Protein  Subunits in Different Neuronal PathwaysMaking the affinity adaptor a part of the effector in the
(A) Visual transduction pathway.visual signaling pathway allows efficient targeting of
(B) Putative pathway of Go-dependent control of G protein-gatedRGS9-1 to the activated G protein-effector complex inwardly rectifying K channels in striatum. The affinity adapters are
(Gt-PDE), thus providing timely signal termination. highlighted in dark red (see text for explanations).
Meanwhile, the low affinity between RGS9-1 and free
Gt prevents Gt discharge before it activates PDE (Fig- and Luscher, 2002, for more recent updates). Third,
ure 4A; see Arshavsky and Pugh, 1998, for a more de- RGS9-2 accelerates the kinetics of GIRK channels acti-
tailed discussion). vated by -opioid or D2 dopamine receptors (Granne-
Alternatively, placing the affinity adaptor on an RGS man et al., 1998; Kovoor et al., 2000; Garzon et al., 2001).
protein, as in the case of RGS9-2, allows specific RGS Another intriguing aspect of the similarities between
targeting of free activated G subunits. This appears PDE and the C terminus of RGS9-2 revealed in this
beneficial for pathways that utilize G protein  subunits study is that these similarities hint at the possibility of
for signal transmission (Clapham and Neer, 1997; Das- a common evolutionary origin of these proteins. This
cal, 1997). In these pathways, RGS proteins determine idea is consistent with close localization of RGS9 and
the duration of signaling events by stimulating GTP hy- rod PDE genes on the same chromosome (within loci
drolysis on free G subunits, which is followed by a 17q24-17q25 in the human genome). One could specu-
reassociation of G·GDP with G that leads to the late that either the PDE gene originated from a duplica-
termination of physiological response (Arshavsky and tion of a portion of the RGS9 gene, or alternatively,
Pugh, 1998; Ross and Wilkie, 2000). Figure 4B illustrates that the 3 portion of the RGS9 gene originated from
the putative striatal pathway where the role of the affinity a duplication of the PDE gene (cf. Meyer, 2003). For
adaptor is played by the C terminus of RGS9-2. The example, the visual signaling cascade might have
following evidence makes the existence of such a path- evolved from a duplication of the 3 portion of the RGS9
way likely. First, all of its components (Go, RGS9-2, and gene, resulting in the emergence of a PDE prototype.
G protein-gated inwardly rectifying K [GIRK] channels) This prototype would already be able to mediate G pro-
are present in striatal neurons (Worley et al., 1986; Greif tein-RGS protein interactions and perhaps eventually
acquired the ability to regulate the activity of the ef-et al., 1995; Thomas et al., 1998; Granneman et al., 1998;
fector, PDE.Rahman et al., 1999; Pruss et al., 2003). Second, the 
subunits of Go/Gi proteins have been shown to couple the
Experimental Proceduresactivation of m2 muscarinic, D2 dopamine, and -opioid
receptors to the modulation of GIRK channels’ activity DNA Constructs and Proteins
in model systems (see Dascal, 1997, for a review and The coding region of RGS9-2 was amplified by PCR from cDNA
containing the mouse RGS9-2 gene (a gift from Dr. S. Gold) usingGranneman et al., 1998; Zhang et al., 2002; and Blanchet
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specific upstream and downstream primers containing BamHI and agarose beads were equilibrated with a binding buffer containing
20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 2 mM MgCl2, 10 M GDP,EcoRI sites, respectively. The PCR product was cloned into a modi-
fied version of the baculovirus transfer vector pVL1392 digested at 0.25% lauryl sucrose, and 50 g/ml bovine serum albumin. The
beads were then incubated on ice for 20 min with 50 l of 5 Mthe corresponding restriction sites (Skiba et al., 2001). The resulting
construct encoded RGS9-2 preceded by an amino acid sequence His6-tagged RGS9·G5 complexes and then washed with 500 l of
the binding buffer. The washed beads were resuspended in 50 lcontaining a His6-tag and thrombin cleavage site. Site-directed sub-
stitutions of RGS9-2 amino acids 662–667 for alanines were intro- binding buffer containing 250 nM of either Gt or Go. 10 mM NaF
and 30M AlCl3 (yielding AlF4) and/or PDE (1M final) were addedduced by PCR using a BamHI containing the upstream primer and
the mutagenic primer 5-CCCTTCCGCCAGGCTCGCCGCGGCGGC when necessary. The samples were incubated on ice for 10 min
with occasional shaking. The beads were spun down and washedGGCGGCTTCTT-3 followed by reamplification using a 3 flanking
primer containing an EcoRI site. Deletion of 45 C-terminal amino twice with 1 ml of the binding buffer supplemented with 20 mM
imidazole. NaF, AlCl3, and PDEwere also present in samples initiallyacids of RGS9-2 (631–675) was performed by PCR using primer
5-GATGAATTCAGATCTGGAAAAAGTTGGCTAC-3 also containing containing these components. Bound G subunits were eluted from
the beads with 50 l SDS-PAGE sample buffer. 10 l aliquots of thean EcoRI site and the upstream BamHI-containing primer. The re-
gion encoding the C-terminal part of RGS9-2 (aa 467–675) was am- eluates were then subjected to SDS-PAGE. The bound G subunits
were detected using commercial polyclonal antibodies against eachplified by PCR using primer 5-TGACGGATCCCCAGGTCAGCACTT
GGC-3 containing BamHI and the downstream EcoRI primer. The subunit from Santa Cruz Biotechnology.
resulting PCR products were treated with BamHI and EcoRI endonu-
cleases and cloned into the pVL1392 plasmid in place of the wild- Acknowledgments
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